Projects funded by the NCN
FGFR2/Nrf-2 axis in luminal breast cancer and the effects on cell growth and response to anti-ER drugs
2020/37/N/NZ3/01401
Keywords:
FGFR2 Nrf-2 luminal A breast cancer
Descriptors:
- NZ3_001:
- NZ3_007:
- NZ5_003:
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution :
Gdański Uniwersytet Medyczny, Międzyuczelniany Wydział Biotechnologii Uniwersytetu Gdańskiego i Gdańskiego Uniwersytetu Medycznego
woj. pomorskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 19 - announced on 2020-03-16
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2021-02-05
Project end date (Y-m-d): 2025-02-04
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugsAuthors:Monika Gorska-Arcisz, Marta Popeda, Marcin Braun, Dominika Piasecka, Joanna I. Nowak, Kamila Kitowska, Grzegorz Stasilojc, Marcin Okroj, Hanna M. Romanska, Rafal SadejAcademic press:Cellular & Molecular Biology Letters (rok: 2024, tom: 29, strony: numer artykułu: 71), Wydawca: Springer NatureStatus:PublishedDOI:10.1186/s11658-024-00586-6 - link to the publication